论文部分内容阅读
目的:评价单磷酸阿糖腺苷与康复新液联用对小儿疱疹性口腔炎的临床疗效。方法:选取2014年6月—2016年6月期间收治的疱疹性口腔炎患儿84例,将其随机分为对照组和治疗组(每组42例);对照组患儿给予常规用药方案治疗,治疗组患儿在对照组基础上加用康复新液与单磷酸阿糖腺苷治疗,比较两组患儿治疗后的口腔炎症消失时间、治疗总时间,以及治疗后的总有效率和不良反应的发生率。结果:治疗组患儿用药后口腔炎症消失时间和治疗总时间明显短于对照组(P<0.05),治疗的总有效率明显高于对照组(P<0.05),用药期间不良反应的发生率明显低于对照组(P<0.05)。结论:单磷酸阿糖腺苷与康复新液联用治疗小儿疱疹性口腔炎的临床疗效较佳,口腔炎症消失时间和治疗总时间较短,不良反应的发生率较低。
Objective: To evaluate the clinical efficacy of adenosine monophosphate combined with Kangfuxin solution in the treatment of pediatric herpetic stomatitis. Methods: Eighty-four children with herpetic stomatitis admitted from June 2014 to June 2016 were randomly divided into control group and treatment group (42 cases in each group). The control group was given routine medication regimen , The treatment group children in the control group plus Kangfuxin solution and monophosphate monophosphate treatment, compared two groups of children after treatment of oral inflammation disappeared, the total time of treatment, and the total effective rate after treatment and poor The incidence of reaction. Results: The disappearance time and total treatment time of oral inflammation in treatment group were significantly shorter than those in control group (P0.05), and the total effective rate of treatment group was significantly higher than that of control group (P0.05). The incidence of adverse reactions Significantly lower than the control group (P <0.05). CONCLUSION: The combination of adenosine monophosphate and Kangfuxinye is better in the treatment of pediatric herpetic stomatitis. The disappearance of oral inflammation and the total duration of treatment are short, and the incidence of adverse reactions is low.